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self blood glucose monitoring, a mean of 3 times per day during the whole period. Detailed history and laboratory examinations were performed at diagnosis, at 1 month and subsequently every 3 months [2] . Chemical hypoglycaemia was defined as blood glucose levels of 2.76 mmol/l or less. The monthly incidence of chemical hypoglycaemic episodes is shown in Table 1 . It is evident that there was no difference in the number of hypoglycaemic episodes in both groups of patients. Nor did we find differences in the mean periodic blood glucose values, as estimated from the 53,000 self blood glucose estimations performed by the 30 juvenile patients over 2 years. During the first year, one patient receiving porcine insulin, had 2 episodes of symptomatic hypoglycaemia at night, one with convulsions. Blood glucose during one of the episodes was 1.88 mmol/I. This same patient had during the second year an additional 4 episodes of symptomatic hypoglycaemia, all before dawn, 3 of them with questionable loss of consciousness. In one of them blood glucose was 2.76 mmol on the same morning. Another patient also receiving porcine insulin had 8 episodes of symptomatic hypoglycaemia, all during the second year. Most hypoglycaemic episodes occurred before dawn. Blood glucose measured during one of the events was 1.60-2.54 mmol/l, with no convulsions.
The above observation confirms our previous study that a comprehensive therapeutic approach by a multidisciplinary team [3] induces a high degree of compliance on the part of the patient. In conclusion, this close follow-up demonstrated no difference between human and porcine insulin in regard to hypoglycaemic episodes, as well as diabetes control during the first 24 months of the disease [2] . We wish to add to Dr. Berger's editorial conclusion [1] that human insulin preparations do not cause more hypoglycaemia than porcine insulin. We have recently analysed in a double blind study 30 newly diagnosed juvenile Type 1 (insulin-dependent) diabetic patients with a mean age of 11.7+_3.4 years who were followed closely for 2 years. Fourteen patients were treated with human insulin (2 daily insulin injections of mixed human Monotard and Actrapid (Novo, Denmark) and 16 patients with a highly purified porcine preparation (Monotard and Actrapid MC, Novo, Denmark). The patients were followed by our multidisciplinary team and performed
Variability of the first phase insulin response to intravenous glucose
Dear Sir,
The very interesting study recently published on these pages by Smith et al. [1] conceptualized a component of B-cell function that has recently and not so recently attracted a good deal of attention [2] . The so-called early phase insulin response of a rapid intravenous 
